Dr. B. S. Ajaikumar is a pioneering oncologist‑entrepreneur whose vision and grit transformed cancer care in India through HealthCare Global Enterprises Ltd. (HCG). Trained in medicine at St. John’s Medical College, Bangalore, he went on to complete residency in oncology at the University of Virginia Hospital and fellowship in radiation and medical oncology at the renowned MD Anderson Cancer Center, Houston, USA.

After years of practicing in the U.S., he returned to India driven by a conviction that advanced cancer care must be accessible and affordable. In 2003 he laid the foundation of what became HCG—a hub‑and‑spoke network enabling cutting‑edge oncology care, even in smaller towns. Under his stewardship, HCG has grown to become one of South Asia’s leading cancer‑care providers, integrating high‑end technologies such as CyberKnife™, TrueBeam™, molecular imaging, bone‑marrow transplants, and genomics‑enabled precision medicine, and expanding into fertility care through the Milann brand.

Beyond clinical care, Dr. Ajaikumar’s entrepreneurial spirit led him to launch the Inviga Healthcare Fund (IHF) in 2024, a private‑equity initiative aimed at empowering Indian healthcare entrepreneurs, scientists, and clinicians—underscoring his broader commitment to strengthening the country’s healthcare ecosystem.

His work has earned him multiple accolades, including the Ernst & Young Entrepreneur of the Year Award, the CII Regional Emerging Entrepreneurs Award, the B. C. Roy Award, and the Karnataka Rajyotsava Award—testaments to both his medical excellence and his leadership in healthcare innovation.

Through a blend of medical mastery, entrepreneurial foresight, and deep social commitment, Dr. B. S. Ajaikumar redefined cancer care in India—turning what was once a privilege into a mission of equality, quality, and hope for all.